Dry Eye and Mood: Unveiling the Link in Sjögren's Syndrome
"Could your dry eyes be affecting your mental well-being? New research highlights the psychological impact of dry eye disease in patients with primary Sjögren's syndrome."
Primary Sjögren's syndrome (pSS) is a chronic autoimmune disease primarily affecting moisture-producing glands, leading to dry eyes and dry mouth. While the physical symptoms are well-recognized, the impact of pSS extends beyond the body, significantly affecting patients' mental and emotional health.
A recent study highlighted how pSS could significantly impair the quality of life (QoL) of patients, emphasizing the importance of measuring QoL in comprehensive disease management. However, an important factor is often overlooked: the role of dry eye disease (DED) in influencing psychological status and overall quality of life in pSS patients.
This article explores the potential link between dry eye disease and psychological well-being in individuals with primary Sjögren's syndrome, shedding light on the importance of considering and managing dry eye symptoms as part of a holistic approach to patient care.
The Overlooked Impact of Dry Eye Disease on Mental Health

Dry eye disease, a common manifestation of pSS, involves autoimmune destruction of the lacrimal gland and subsequent ocular surface damage. This can lead to a range of uncomfortable symptoms, including dryness, grittiness, pain, and blurred vision. But the impact doesn't stop there.
- Autoimmune destruction of lacrimal glands causes dry eye in pSS.
- Dry eye symptoms include discomfort, pain, and vision problems.
- DED is linked to depression, anxiety, and stress.
- Dry eye symptoms can worsen the mental health of pSS patients.
A Call for Comprehensive Care
Given the complex interplay between dry eye disease and mental health in Sjögren's syndrome, it's crucial for healthcare professionals to adopt a comprehensive approach to patient care. This includes not only assessing and managing the physical symptoms of dry eye but also evaluating the patient's psychological status and quality of life.
Future studies should incorporate both objective measures of dry eye (tear film break-up time, Schirmer score, ocular staining) and subjective symptom assessments (discomfort, pain, dryness, grittiness) to gain a more complete understanding of the impact of DED on QoL in pSS patients. Such integrated analyses will be invaluable for determining the true burden of the disease and developing targeted interventions.
By acknowledging and addressing the psychological impact of dry eye disease, healthcare providers can significantly improve the overall well-being and quality of life for individuals living with primary Sjögren's syndrome.